CN102341115A - 用于预防或治疗性处理初始阶段的皮肤肿瘤的肽 - Google Patents

用于预防或治疗性处理初始阶段的皮肤肿瘤的肽 Download PDF

Info

Publication number
CN102341115A
CN102341115A CN2010800105516A CN201080010551A CN102341115A CN 102341115 A CN102341115 A CN 102341115A CN 2010800105516 A CN2010800105516 A CN 2010800105516A CN 201080010551 A CN201080010551 A CN 201080010551A CN 102341115 A CN102341115 A CN 102341115A
Authority
CN
China
Prior art keywords
peptide
therapeutic treatment
skin
desstatide
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800105516A
Other languages
English (en)
Chinese (zh)
Inventor
R·因萨博罗纳特
M·昆塔尼拉阿维拉
J·多托尔德拉斯埃雷里亚斯
Original Assignee
Isdin SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isdin SA filed Critical Isdin SA
Publication of CN102341115A publication Critical patent/CN102341115A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/179—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2010800105516A 2009-03-06 2010-03-04 用于预防或治疗性处理初始阶段的皮肤肿瘤的肽 Pending CN102341115A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200900694A ES2347627B1 (es) 2009-03-06 2009-03-06 Peptido para el tratamiento profilactico o terapeutico de tumores de la piel en estadios iniciales.
ESP200900694 2009-03-06
PCT/ES2010/070121 WO2010100310A1 (es) 2009-03-06 2010-03-04 Péptido para el tratamiento profiláctico o terapéutico de tumores de la piel en estadios iniciales

Publications (1)

Publication Number Publication Date
CN102341115A true CN102341115A (zh) 2012-02-01

Family

ID=42709234

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800105516A Pending CN102341115A (zh) 2009-03-06 2010-03-04 用于预防或治疗性处理初始阶段的皮肤肿瘤的肽

Country Status (13)

Country Link
US (1) US8658599B2 (https=)
EP (1) EP2404611A4 (https=)
JP (1) JP2012519671A (https=)
CN (1) CN102341115A (https=)
AR (1) AR075783A1 (https=)
AU (1) AU2010219857A1 (https=)
BR (1) BRPI1013363A8 (https=)
CA (1) CA2753461A1 (https=)
ES (1) ES2347627B1 (https=)
MX (1) MX2011009225A (https=)
RU (1) RU2011140477A (https=)
TW (1) TW201036625A (https=)
WO (1) WO2010100310A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021037290A3 (zh) * 2019-08-27 2021-04-15 南京安吉生物科技有限公司 一种融合多肽及其应用

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9353149B2 (en) * 2013-05-10 2016-05-31 Southern Research Institute Compounds, compositions and methods for the treatment of diseases through inhibiting TGF-β activity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1328569A (zh) * 1998-11-24 2001-12-26 纳瓦拉公司科学与技术研究所 TGFβ1－抑制肽
CN101340927A (zh) * 2005-10-24 2009-01-07 西玛生物医学信息公司 TGF-β1抑制性多肽在制备免疫反应调节剂上的用途
CN102123737A (zh) * 2008-06-13 2011-07-13 西马生物医学计划公司 用于生物活性化合物施用的轭合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5650367B2 (ja) * 2004-02-27 2015-01-07 アンティセンス ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1328569A (zh) * 1998-11-24 2001-12-26 纳瓦拉公司科学与技术研究所 TGFβ1－抑制肽
CN101340927A (zh) * 2005-10-24 2009-01-07 西玛生物医学信息公司 TGF-β1抑制性多肽在制备免疫反应调节剂上的用途
CN102123737A (zh) * 2008-06-13 2011-07-13 西马生物医学计划公司 用于生物活性化合物施用的轭合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
G. HAN 等: "Distinct mechanisms of TGF-1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis", 《JOURNAL OF CLINICAL INVESTIGATION》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021037290A3 (zh) * 2019-08-27 2021-04-15 南京安吉生物科技有限公司 一种融合多肽及其应用
GB2600594A (en) * 2019-08-27 2022-05-04 Nanjing Anji Biological Tech Co Ltd Fused polypeptide and use thereof

Also Published As

Publication number Publication date
ES2347627B1 (es) 2011-10-10
JP2012519671A (ja) 2012-08-30
ES2347627A1 (es) 2010-11-02
MX2011009225A (es) 2011-10-10
RU2011140477A (ru) 2013-04-27
BRPI1013363A2 (pt) 2016-03-29
AU2010219857A1 (en) 2011-10-06
BRPI1013363A8 (pt) 2016-07-19
EP2404611A1 (en) 2012-01-11
US8658599B2 (en) 2014-02-25
US20120065144A1 (en) 2012-03-15
CA2753461A1 (en) 2010-09-10
TW201036625A (en) 2010-10-16
EP2404611A4 (en) 2012-11-21
WO2010100310A1 (es) 2010-09-10
AR075783A1 (es) 2011-04-27

Similar Documents

Publication Publication Date Title
CN101111222A (zh) 刺激胶原蛋白合成和/或kgf表达的方法
Lin et al. Neuregulin-1, a microvascular endothelial-derived protein, protects against myocardial ischemia-reperfusion injury
JP6921131B2 (ja) 生物活性フルベート画分の組成物及びその使用
US20210369697A1 (en) Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
SK147199A3 (en) Leptin as an inhibitor of tumor cell proliferation
CN110494145A (zh) 治疗脂蛋白代谢障碍的化合物
EP2512468B1 (en) METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS
CN103505448B (zh) 大黄酸在制备治疗胰腺纤维化药物中的应用
CN102341115A (zh) 用于预防或治疗性处理初始阶段的皮肤肿瘤的肽
TWI496579B (zh) 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途
KR102206017B1 (ko) Parp1 저해제를 포함하는 피부 섬유화 질환 치료용 약학적 조성물
JP2022551672A (ja) 乳癌治療法
EP3435990B1 (en) Stable pharmaceutical compositions for topical administration and uses thereof
TW201722457A (zh) 短合成胜肽及其用途
López-Saura et al. Intralesional human recombinant epidermal growth factor for the treatment of advanced diabetic foot ulcer: from proof of concept to confirmation of the efficacy and safety of the procedure
EP3700513B1 (en) Non-steroidal selective glucocorticoid receptor agonistic modulators (segrams) and uses thereof
KR102561856B1 (ko) 염증성 질환의 예방, 개선 또는 치료용 조성물
US20240226233A1 (en) Composition comprising zag-derived peptide for improving scars and keloids
KR102065150B1 (ko) 이소트레티노인-펩타이드 결합체를 유효성분으로 포함하는 비만의 예방 또는 치료용 조성물
JP2026046075A (ja) 細胞性粘菌由来分化誘導因子を含む皮膚線維化疾患の予防または治療のための局所塗布剤
JP2018021044A (ja) 脱毛症及び／又は毛髪色素脱失を治療するためのｐｅｄｆ由来のポリペプチドの使用
JP4477504B2 (ja) 鎮痒剤
WO2024227063A1 (en) Methods and compositions for treating obesity, skin disorders, and/or eye disorders
KR20190140761A (ko) 방사선 항암 치료 보조용 약학적 조성물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DIGE NA BIOTECHNOLOGY LTD.

Free format text: FORMER OWNER: ISDIN S. A.

Effective date: 20120816

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20120816

Address after: Pamplona

Applicant after: Digna biotechnology Ltd

Address before: Barcelona

Applicant before: Isdin S. A.

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120201